- Home
- switzerland
- Companies
Refine by
Medical Industry Technology In Switzerland
27 companies found
Technologybased inDüdingen, SWITZERLAND
ORELL Tec AG (previously OLAER (Switzerland) AG) was founded in 1969 in Colombes (F) as a fiduciary of OLAER Industries SA. It was in 1976 that we were able to move to the facilities where we are currently locat-ed, in Düdingen (in the Canton of ...
OLAER bladder accumulators are ideal for any application. They can be recommended for use anywhere, where accumulators are used as energy reserve such as in hydrostatic bearings, lubricating oil supplies, chucking systems on machine tools, safety ...
Technologybased inSchlieren, SWITZERLAND
Redbiotec is a private biotech company in Zurich-Schlieren. Founded in 2006 as a spin-off of ETH Zürich, the company has won several awards, including the renowned W.A. de Vigier Award. In 2015, Pfizer acquired Redvax (a Redbiotec spin-off) for its ...
Redbiotec specializes in developing high-quality vaccines to fight difficult diseases. After successfully spinning out the CMV vaccine program that was acquired by Pfizer, Redbiotec is currently developing HSV-2 therapeutic vaccine ...
Technologybased inMaur (Zurich), SWITZERLAND
We are delighted to introduce our current range of modular systems and individual components to you on the following pages. When Rolf Sieber first entered the market with SITEC in 1984, he could never have imagined the success the company enjoys ...
Technologybased inSolothurn, SWITZERLAND
Axino uses the power of the Internet of Things (IoT) to help our customers achieve their sustainability goals and reduce their carbon footprint. We simultaneously address two of the main drivers of climate change: fresh food and refrigeration. Our ...
Axino’s solution combines Swiss precision measurements with cutting-edge Algorithms. 5+ years of research: Developed in close collaboration with Switzerland’s largest retailer, a leading research institute and supported by the ...
Technologybased inGeneve, SWITZERLAND
ITS Water Group specializes in providing advanced chemical reagents and engineering services tailored for effective water and wastewater treatment solutions. The company focuses on delivering innovative technologies for municipal and industrial ...
Technologybased inSchlieren, SWITZERLAND
The biotech-company EraCal Therapeutics Ltd. is a spin-off from the University of Zurich and Harvard University. The company is privately held by a biotech-specialized investor base incl. BERNINA BioInvest, Redalpine, and UZH Life Sciences ...
EraCal’s platform enables unbiased and large-scale in vivo drug discovery in zebrafish larvae. The journal Science Advances published part of EraCal’s translational proof of concept. Such phenotypic strategies are capable of identifying ...
Technologybased inKemptthal, SWITZERLAND
Haelixa is the Swiss knife of traceability solutions: extreme precision and functionality in any scenario. In a world where supply chains have become complex and disruptions have increased, traceability is critical to ensure transparency. While ...
Technologybased inNew York, NEW YORK (USA)
Stemline Therapeutics is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics. The goal of our dedicated team of scientists, specialists, researchers, and developers is to build ...
SL-801 is a structurally novel, oral, small molecule, reversible inhibitor of exportin-1 (XPO1), a nuclear transport protein implicated in both solid tumors and hematologic malignancies. SL-801 has demonstrated preclinical in vitro and in vivo ...
Technologybased inBasel, SWITZERLAND
T3 Pharmaceuticals was founded in May 2015 by Simon Ittig, Christoph Kasper, Marlise Amstutz and Helmut Kessmann as a spin-off of the University of Basel. The team has developed an efficient protein delivery technology that is based on the use of ...
Technologybased inOttawa, SWITZERLAND
Orion Biotechnology is unlocking the therapeutic potential of previously undruggable G Protein-Coupled Receptors (GPCRs) with a novel drug modality, proven discovery platform and best-in-class molecules. The company is advancing a diversified ...
G Protein-Coupled Receptors (GPCRs) are involved in a wide range of physiological and pathological processes and represent a large class of drug targets accounting for >30% of all drugs on the market. These drugs, however, only cover 15% of the ...
Technologybased inWaiblingen, GERMANY
Syntegon stands as a strategic partner in the pharmaceutical and food processing and packaging sectors. Utilizing a heritage of 160 years, Syntegon's portfolio extends to standalone machines and comprehensive system solutions for primary and ...
Technologybased inEindhoven, NETHERLANDS
Xeltis is a clinical-stage medical device company pioneering a restorative approach in cardiovascular therapy. RestoreX™, Xeltis technology platform, is the world’s first polymer-based technology designed to enable natural restoration of ...
The aXess graft is a restorative, synthetic, electrospun blood vessel for arteriovenous hemodialyisis access, overtime turning into a living vessel made of patient’s own ...
Technologybased inTempe, ARIZONA (USA)
Align Technology is a global medical device company that is changing lives through better smiles. We reimagine and reinvent the way orthodontic and restorative treatment is presented and delivered to millions of people around the world. We believe a ...
The Invisalign system is the most advanced clear aligner system in the world. Backed by two decades of innovation, the Invisalign system has helped bring smiles to over 9.6 million people including over 2.4 million ...
Technologybased inWadenswil, SWITZERLAND
3Brain is the world’s first company to connect cells with sophisticated silicon chips in cell culture plates. Stemming from our passion for technology and scientific progress, our co-founders have worked for more than 15 years on CMOS-powered ...
The external IO Connector Box facilitates the access to the BioCAM X and BioCAM DupleX HD-MEA channels and internal modules (like the stimulation module). It features: 4 output stimulation channels, 1 input stimulation channel, 3 digital In/Out ...
Technologybased inBubendorf, SWITZERLAND
CIS Pharma is an innovator in the life science industry in the field of Oncology and Ophthalmolog. We were awarded with the European Frost & Sullivan Technology Innovation Award for our unique smart polymer technologyœ, says Christoph Schäfer, CEO ...
Werner Schäfer, the founder of CIS Pharma, envisioned the synthesis of a bio-inspired polymer for tissue regeneration and site-specific drug delivery. We have generated a platform of proprietary polymers together with a toolkit to create ...
Technologybased inLausanne, SWITZERLAND
Xsensio is an innovation-driven digital health company dedicated to solving one of the biggest challenges in healthcare: the lack of real-time, continuous monitoring of relevant health parameters. To achieve this vision, Xsensio is building the ...
Xsensio considerably expands the potential of wearable products with the development of a breakthrough wearable device that tracks – not physical data like today’s devices – but biochemical data in the interstitial fluid (ISF). At ...
Technologybased inZürich, SWITZERLAND
Amcor is a world leader in innovative packaging. The company added a range of diverse packaging interests to its traditional papermaking activities. This was achieved through creating new business partnerships and making strategic acquisitions in ...
Technologybased inBasel, SWITZERLAND
Aurealis Therapeutics, a Swiss-Finnish private biopharmaceutical company, is now entering the clinical trial phase with its patented three-in-one combination product AUP-16 for chronic non-healing wounds and other regenerative diseases. The ...
Our new approach to chronic wound healing moves far beyond symptom ...
Technologybased inSchlieren, SWITZERLAND
We want to empower people to deal with their malignant cells through their own immune system just like we deal with viral infections. Today’s cancer immunotherapies are powerful but, to the detriment of their effect, not very tumor-selective. ...
CDR-Life’s T cell engaging antibodies are potentially transformative in the field of cancer immunotherapies» Prof. Markus G. Manz, MD, Head of Medical Oncology and Hematology at University Hospital and University of Zurich, Switzerland. ...
Technologybased inGeneve, SWITZERLAND
STALICLA has developed the first neurodevelopmental disorder-specific precision medicine discovery platform with an initial application in autism spectrum disorder (ASD). Until now, patient diagnosis and drug development for ASD and other NDDs have ...
DDS applies AI-driven and systems biology precision medicine approaches to patient data sets. Bringing together computational biologists, human geneticists, data scientists, chemo-informaticians and developers, DDS ensures that STALICLA’s ...